You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.

DUBLIN, April 6, 2020 /PRNewswire/ -- The "Dengue Testing Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The dengue testing market will show rapid growth due to the increasing incidences of dengue cases, change in climate is likely to increase the burden of dengue fever and increasing awareness campaigns to educate about the ills of dengue.The overall incidence of dengue, as well as the explosive outbreaks of dengue, has been increasing dramatically over the last several years. According to the World Health Organization, the number of cases reported has increased from 2.2 million in 2010 to over 3.34 million in 2016.Although the full global burden of the disease is uncertain, the initiation of activities to record all dengue cases partly explains the sharp increase in the number of cases reported in recent years. Therefore not only the number of cases is increasing as the disease spreads to new areas, but explosive outbreaks are occurring.Among travelers returning from low- and middle-income countries, dengue is the second most diagnosed cause of fever after malaria. Therefore the rising prevalence of dengue virus has raised the demand for more diagnostic kits, which is expected to drive the dengue testing market in the near future.There is also a change in the climate of European countries, that has been a great impact on the vector distribution and potential disease transmission. This change in climate is likely to increase the burden of dengue fever, and this, in turn, will propel the growth of the market of dengue testing.Key Market TrendsELISA-Based Tests Expected to DominateThe most widely used method for diagnosing dengue is an enzyme-linked immunosorbent assay (ELISA) which measures anti-DENV IgM or IgG antibodies in patient serum. The early diagnosis and management of dengue help to reduce the morbidity and mortality rates of severe forms of dengue disease as well as decrease the risk of wider outbreaks.The enzyme-linked immunosorbent assay (ELISA) is capable of detecting NS1 antigens and differentiating among the four dengue virus serotypes. ELISA kits are found to have superior sensitivity when compared to RDTs. Because of their superior performance, ELISAs would be the recommended diagnostic choice when laboratories with trained personnel and equipment are available.Asia-Pacific is Found Leading the Dengue Testing MarketAsia-Pacific is found to be leading in the global dengue testing market as there are millions of cases of dengue infection every year. In India, there have been more than 300 percent hike in the dengue cases since 2009 and even the total number of deaths in 2017 was the highest in the last decade. Dengue fever is most common in Southeast Asia and the disease has been increasing rapidly.There are also several research organizations that have shown interest in developing new lines of medication for treating dengue.The market for dengue testing in the Asia-Pacific is thus expanding at a fast pace on account of the rising incidence of infectious diseases, including dengue, in India, Pakistan, and Sri Lanka.Competitive LandscapeThere has been a presence of a considerable number of companies that are significantly contributing to market growth. Recently the Telenor Heath's Tonic has launched the Home Diagnostic Tests service for dengue with video consultation through their Tonic App.The major companies that are functioning in the global dengue testing market include Abbott Laboratories, NovaTec Immundiagnostica GmbH, Euroimmun AG (PerkinElmer), Quest Diagnostics, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., and InBios International, Inc.Key Topics Covered 1. INTRODUCTION1.1 Study Assumptions and Market Definition1.2 Scope of the Study2. RESEARCH METHODOLOGY3. EXECUTIVE SUMMARY4. MARKET DYNAMICS4.1 Market Overview4.2 Market Drivers4.2.1 Increasing Number of Dengue Cases4.2.2 Change in Climate is Likely to Increase the Burden of Dengue Fever 4.2.3 Increasing Awareness Campaigns to Educate About the Ills of Dengue4.3 Market Restraints4.3.1 Unavailability of Effective Diagnostic Tools4.3.2 High Price of Existing Test Kits4.4 Industry Attractiveness - Porter's Five Forces Analysis4.4.1 Bargaining Power of Suppliers4.4.2 Bargaining Power of Consumers4.4.3 Threat of New Entrants4.4.4 Threat of Substitute Products/Services4.4.5 Intensity of Competitive Rivalry4.5 Analyst's Perspective - The Impact of COVID-19 on the Market5. MARKET SEGMENTATION5.1 By Product Type5.1.1 ELISA-based Tests5.1.2 RT-PCR-based Tests5.1.3 Dengue IgG/IgM Rapid Test5.1.4 Other Tests5.2 By End User5.2.1 Hospitals5.2.2 Diagnostic Centers5.2.3 Other End Users5.3 By Geography5.3.1 North America5.3.1.1 United States5.3.1.2 Canada5.3.1.3 Mexico5.3.2 Europe5.3.2.1 United Kingdom5.3.2.2 Germany5.3.2.3 France5.3.2.4 Italy5.3.2.5 Spain5.3.2.6 Rest of Europe5.3.3 Asia-Pacific5.3.3.1 China5.3.3.2 Japan5.3.3.3 India5.3.3.4 Australia5.3.3.5 South Korea5.3.3.6 Rest of Asia-Pacific5.3.4 Middle East & Africa5.3.4.1 GCC5.3.4.2 South Africa5.3.4.3 Rest of Middle East & Africa5.4.5 South America5.4.5.1 Brazil5.4.5.2 Argentina5.4.5.3 Rest of South America6. COMPANY PROFILES AND COMPETITIVE LANDSCAPE6.1 Abbott Laboratories6.2 Abnova Corporation6.3 Certest Biotec SL6.4 DiaSorin6.5 F. Hoffmann-La Roche Ltd.6.6 InBios International Inc.6.7 NovaTec Immundiagnostica GmbH6.8 OriGene Technologies6.9 PerkinElmer Inc. (Euroimmun AG)6.10 Thermo Fisher Scientific Inc.7. MARKET OPPORTUNITIES AND FUTURE TRENDS For more information about this report visit https://www.researchandmarkets.com/r/176agc Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

Answer: Dengue Testing Industry Outlook, 2020-2025: The Impact of COVID-19